| |
| |
|
| Insider
Information: |
Ciaramella Giuseppe |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
169,616 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,016,507 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
169,616 |
|
|
| Total
Value |
$4,016,507 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Beam Therapeutics Inc. |
BEAM |
|
2024-04-01 |
169,616 |
2020-09-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
29 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BEAM |
Beam Therapeutics Inc. |
President & CSO |
• – – |
2023-01-03 |
4 |
OE |
$0.67 |
$51,356 |
D/D |
53,729 |
149,691 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
President |
• – – |
2024-04-01 |
4 |
AS |
$32.12 |
$145,632 |
D/D |
(4,534) |
169,616 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
President |
• – – |
2024-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
174,150 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
President and CSO |
• – – |
2023-07-21 |
4 |
OE |
$7.22 |
$659,070 |
D/D |
91,284 |
203,574 |
0 |
- |
|
29 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
